Research analysts at StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Down 3.1 %
Check-Cap stock opened at $0.76 on Monday. Check-Cap has a 12-month low of $0.56 and a 12-month high of $3.45. The stock has a market cap of $4.42 million, a PE ratio of -0.25 and a beta of 0.19. The business’s 50-day moving average price is $1.02 and its two-hundred day moving average price is $1.16.
About Check-Cap
Featured Articles
- Five stocks we like better than Check-Cap
- Quiet Period Expirations Explained
- How to Build the Ultimate Everything ETF Portfolio
- With Risk Tolerance, One Size Does Not Fit All
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.